(RS) Reliance Steel & Aluminum - Ratings and Ratios
Alloy, Aluminum, Brass, Copper, Steel
Dividends
| Dividend Yield | 1.65% |
| Yield on Cost 5y | 4.36% |
| Yield CAGR 5y | 15.18% |
| Payout Consistency | 98.1% |
| Payout Ratio | 34.1% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 24.7% |
| Value at Risk 5%th | 36.8% |
| Relative Tail Risk | -9.28% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.14 |
| Alpha | -15.30 |
| CAGR/Max DD | 0.68 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.407 |
| Beta | 0.752 |
| Beta Downside | 0.699 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.30% |
| Mean DD | 9.70% |
| Median DD | 9.92% |
Description: RS Reliance Steel & Aluminum October 30, 2025
Reliance, Inc. (formerly Reliance Steel & Aluminum Co.) is a diversified metals service center that distributes a broad portfolio of metal alloys-including aluminum, copper, stainless steel, and titanium-to OEMs across the United States and Canada. Its processing services support end-markets such as construction, transportation, aerospace, energy, electronics, and heavy industrial machinery, with sales primarily channeled through small-to-mid-size machine shops and fabricators.
As of FY 2024, the company reported revenue of roughly $11 billion and an operating margin near 7%, reflecting modest pricing power amid volatile steel prices. Inventory turnover has accelerated to 4.2 × annual, indicating tighter working-capital management. The business is highly sensitive to macro-drivers like U.S. housing starts, federal infrastructure spending, and global steel price spreads, which together account for a significant portion of demand fluctuations in the steel sub-industry.
For a deeper quantitative view of RS’s valuation metrics and peer comparison, you may want to explore the company’s profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (728.2m TTM) > 0 and > 6% of Revenue (6% = 835.3m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA -3.94pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 24.22% (prev 20.93%; Δ 3.29pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 1.03b > Net Income 728.2m (YES >=105%, WARN >=100%) |
| Net Debt (1.43b) to EBITDA (1.28b) ratio: 1.12 <= 3.0 (WARN <= 3.5) |
| Current Ratio 4.43 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (52.8m) change vs 12m ago -4.29% (target <= -2.0% for YES) |
| Gross Margin 27.51% (prev 28.34%; Δ -0.83pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 133.5% (prev 136.4%; Δ -2.81pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 19.88 (EBITDA TTM 1.28b / Interest Expense TTM 50.2m) >= 6 (WARN >= 3) |
Altman Z'' 7.40
| (A) 0.32 = (Total Current Assets 4.36b - Total Current Liabilities 984.0m) / Total Assets 10.55b |
| (B) 0.70 = Retained Earnings (Balance) 7.40b / Total Assets 10.55b |
| (C) 0.10 = EBIT TTM 998.1m / Avg Total Assets 10.43b |
| (D) 2.26 = Book Value of Equity 7.31b / Total Liabilities 3.23b |
| Total Rating: 7.40 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 49.61
| 1. Piotroski 4.50pt |
| 2. FCF Yield 4.11% |
| 3. FCF Margin 4.75% |
| 4. Debt/Equity 0.23 |
| 5. Debt/Ebitda 1.12 |
| 6. ROIC - WACC (= 0.99)% |
| 7. RoE 10.09% |
| 8. Rev. Trend -72.43% |
| 9. EPS Trend -77.06% |
What is the price of RS shares?
Over the past week, the price has changed by +2.00%, over one month by +6.06%, over three months by +0.73% and over the past year by -1.63%.
Is RS a buy, sell or hold?
- Strong Buy: 2
- Buy: 1
- Hold: 5
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the RS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 320 | 9.8% |
| Analysts Target Price | 320 | 9.8% |
| ValueRay Target Price | 329.2 | 12.9% |
RS Fundamental Data Overview December 02, 2025
P/E Trailing = 20.329
P/E Forward = 15.5039
P/S = 1.0552
P/B = 1.9992
P/EG = 1.2
Beta = 0.91
Revenue TTM = 13.92b USD
EBIT TTM = 998.1m USD
EBITDA TTM = 1.28b USD
Long Term Debt = 1.38b USD (from longTermDebt, last quarter)
Short Term Debt = 64.8m USD (from shortTermDebt, last quarter)
Debt = 1.69b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.43b USD (from netDebt column, last quarter)
Enterprise Value = 16.12b USD (14.69b + Debt 1.69b - CCE 261.2m)
Interest Coverage Ratio = 19.88 (Ebit TTM 998.1m / Interest Expense TTM 50.2m)
FCF Yield = 4.11% (FCF TTM 662.0m / Enterprise Value 16.12b)
FCF Margin = 4.75% (FCF TTM 662.0m / Revenue TTM 13.92b)
Net Margin = 5.23% (Net Income TTM 728.2m / Revenue TTM 13.92b)
Gross Margin = 27.51% ((Revenue TTM 13.92b - Cost of Revenue TTM 10.09b) / Revenue TTM)
Gross Margin QoQ = 28.25% (prev 27.82%)
Tobins Q-Ratio = 1.53 (Enterprise Value 16.12b / Total Assets 10.55b)
Interest Expense / Debt = 0.85% (Interest Expense 14.4m / Debt 1.69b)
Taxrate = 23.29% (57.7m / 247.7m)
NOPAT = 765.6m (EBIT 998.1m * (1 - 23.29%))
Current Ratio = 4.43 (Total Current Assets 4.36b / Total Current Liabilities 984.0m)
Debt / Equity = 0.23 (Debt 1.69b / totalStockholderEquity, last quarter 7.31b)
Debt / EBITDA = 1.12 (Net Debt 1.43b / EBITDA 1.28b)
Debt / FCF = 2.16 (Net Debt 1.43b / FCF TTM 662.0m)
Total Stockholder Equity = 7.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.90% (Net Income 728.2m / Total Assets 10.55b)
RoE = 10.09% (Net Income TTM 728.2m / Total Stockholder Equity 7.22b)
RoCE = 11.61% (EBIT 998.1m / Capital Employed (Equity 7.22b + L.T.Debt 1.38b))
RoIC = 8.93% (NOPAT 765.6m / Invested Capital 8.57b)
WACC = 7.94% (E(14.69b)/V(16.38b) * Re(8.78%) + D(1.69b)/V(16.38b) * Rd(0.85%) * (1-Tc(0.23)))
Discount Rate = 8.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.63%
[DCF Debug] Terminal Value 72.74% ; FCFE base≈818.1m ; Y1≈693.3m ; Y5≈528.3m
Fair Price DCF = 162.5 (DCF Value 8.50b / Shares Outstanding 52.3m; 5y FCF grow -18.49% → 3.0% )
EPS Correlation: -77.06 | EPS CAGR: -14.81% | SUE: -0.11 | # QB: 0
Revenue Correlation: -72.43 | Revenue CAGR: -2.33% | SUE: 2.02 | # QB: 1
EPS next Quarter (2026-03-31): EPS=4.78 | Chg30d=-0.360 | Revisions Net=+0 | Analysts=4
EPS next Year (2026-12-31): EPS=18.33 | Chg30d=-0.351 | Revisions Net=-3 | Growth EPS=+25.4% | Growth Revenue=+4.4%
Additional Sources for RS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle